David-Alexandre C. Gros - 20 Dec 2021 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Chief Executive Officer, Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for David-Alexandre Gros
Issuer symbol
ELDN
Transactions as of
20 Dec 2021
Net transactions value
+$8,960
Form type
4
Filing time
21 Dec 2021, 15:05:34 UTC
Previous filing
19 Aug 2021
Next filing
02 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELDN Common Stock Purchase $8,960 +2,000 +29% $4.48 9,000 20 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased in an open market transaction in accordance with the Issuer's trading policies.